Haemonetics's total assets for Q4 2025 were $2.45B, a decrease of -3.17% from the previous quarter. HAE total liabilities were $1.63B for the fiscal quarter, a 0.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.